Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

NCT02584309 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma, Soft Tissue
Soft Tissue Sarcoma
Undifferentiated Pleomorphic Sarcoma
Leiomyosarcoma
Liposarcoma
Synovial Sarcoma
Myxofibrosarcoma
Angiosarcoma
Fibrosarcoma
Malignant Peripheral Nerve Sheath Tumor
Epithelioid Sarcoma

Interventions

DRUG: Dexrazoxane
DRUG: Doxorubicin

Sponsor

Washington University School of Medicine